| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 16th February 2021 | Stephen Gordon | 10,000 | Exercise of derivative | $0.67 | $6,700.00 |
| 16th February 2021 | Stephen Gordon | 10,000 | Open or private sale | $31.33 | $313,300.00 |
| 9th February 2021 | Capital Management, L.P. Abrams | 786,664 | Open or private sale | $33.32 | $26,208,733.82 |
| 9th February 2021 | John F Sullivan | 200 | Open or private sale | $34.18 | $6,836.00 |
| 9th February 2021 | John F Sullivan | 8,600 | Exercise of derivative | $0.28 | $2,408.00 |
| 9th February 2021 | John F Sullivan | 8,400 | Open or private sale | $32.78 | $275,352.00 |
| 8th February 2021 | Ventures Fund Iv General Partner Llc Flagship | 71,667 | Open or private purchase | $11.50 | $824,170.50 |
| 8th February 2021 | Ventures Fund Iv General Partner Llc Flagship | 71,667 | Open or private purchase | $11.50 | $824,170.50 |
| 8th February 2021 | Ventures Fund Iv General Partner Llc Flagship | 71,666 | Open or private purchase | $11.50 | $824,159.00 |
| 8th February 2021 | Capital Management, L.P. Abrams | 88,483 | Open or private sale | $26.24 | $2,321,705.44 |
Trans Medics Group
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
TransMedics Group, Inc. focuses on the preservation of human organs for transplant in a near-physiologic condition. The company was founded by Waleed H. Hassanein in October 2018.
Ticker: TMDX
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1756262
Employees: 109
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Oregonian’s parent company will seek federal PPP money
5th March 2021
